Credit Suisse Ag Arcturus Therapeutics Holdings Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 36,987 shares of ARCT stock, worth $626,189. This represents 0.0% of its overall portfolio holdings.

Number of Shares

36,987

Previous 37,246 0.7%

Holding current value

$626,189

Previous $1.17 Million 6.39%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$31.23 - $42.99 $8,088 - $11,134	-259 Reduced 0.7%	36,987 $1.25 Million
Q4 2023 Feb 08, 2024	SELL	$17.71 - $32.97 $134,719 - $250,802	-7,607 Reduced 16.96%	37,246 $1.17 Million
Q3 2023 Nov 13, 2023	SELL	$25.44 - $37.35 $424,669 - $623,483	-16,693 Reduced 27.12%	44,853 $1.15 Million
Q2 2023 Aug 11, 2023	BUY	$23.94 - $32.36 $444,589 - $600,957	18,571 Added 43.21%	61,546 $1.77 Million
Q1 2023 May 10, 2023	BUY	$14.72 - $23.97 $80,238 - $130,660	5,451 Added 14.53%	42,975 $1.03 Million
Q4 2022 Feb 13, 2023	BUY	$14.14 - $23.06 $62,739 - $102,317	4,437 Added 13.41%	37,524 $636,000
Q3 2022 Nov 10, 2022	BUY	$13.05 - $22.13 $108,432 - $183,878	8,309 Added 33.53%	33,087 $490,000
Q2 2022 Aug 12, 2022	SELL	$12.26 - $31.17 $10,580 - $26,899	-863 Reduced 3.37%	24,778 $390,000
Q1 2022 May 16, 2022	SELL	$17.64 - $39.57 $6,403 - $14,363	-363 Reduced 1.4%	25,641 $692,000
Q4 2021 Feb 14, 2022	BUY	$34.2 - $47.56 $49,008 - $68,153	1,433 Added 5.83%	26,004 $963,000
Q3 2021 Nov 12, 2021	BUY	$27.88 - $58.25 $356,529 - $744,901	12,788 Added 108.53%	24,571 $1.17 Million
Q2 2021 Aug 16, 2021	SELL	$25.79 - $42.11 $75,281 - $122,919	-2,919 Reduced 19.85%	11,783 $398,000
Q1 2021 May 14, 2021	SELL	$38.75 - $86.92 $1.35 Million - $3.03 Million	-34,829 Reduced 70.32%	14,702 $607,000
Q4 2020 Feb 12, 2021	SELL	$34.61 - $123.66 $900,898 - $3.22 Million	-26,030 Reduced 34.45%	49,531 $2.15 Million
Q3 2020 Nov 13, 2020	BUY	$37.49 - $63.19 $2.22 Million - $3.75 Million	59,346 Added 365.99%	75,561 $3.24 Million
Q2 2020 Aug 12, 2020	SELL	$12.66 - $58.27 $39,803 - $183,200	-3,144 Reduced 16.24%	16,215 $757,000
Q1 2020 May 13, 2020	SELL	$9.31 - $18.26 $369,085 - $723,899	-39,644 Reduced 67.19%	19,359 $263,000
Q4 2019 Feb 12, 2020	BUY	$8.93 - $12.41 $526,896 - $732,227	59,003 New	59,003 $641,000

Others Institutions Holding ARCT

# of Institutions

179

Shares Held

25.6M

Call Options Held

195K

Put Options Held

133K

View Full List

About Arcturus Therapeutics Holdings Inc.

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $450M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

More about ARCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account